Atrimed Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 8.50 Cr
as on 20-12-2024
- Paid Up Capital ₹ 8.16 Cr
as on 20-12-2024
- Company Age 21 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.41 Cr
as on 20-12-2024
- Revenue 44.96%
(FY 2021)
- Profit 197.83%
(FY 2021)
- Ebitda 12090.12%
(FY 2021)
- Net Worth 33.47%
(FY 2021)
- Total Assets 18.14%
(FY 2021)
About Atrimed Pharmaceuticals
The Corporate was formerly known as Atrimed Herbals Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 8.50 Cr and a paid-up capital of Rs 8.16 Cr.
The company currently has active open charges totaling ₹2.41 Cr.
Hrishikesh Damle, Ganju Krishen, Latha Damle, and One other member serve as directors at the Company.
- CIN/LLPIN
U02423KA2003PTC032200
- Company No.
032200
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Jul 2003
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Atrimed Pharmaceuticals?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Latha Damle  | Director | 09-Sep-2021 | Current |
| Hrishikesh Damle | Director | 03-Jul-2003 | Current |
Ganju Krishen  | Director | 25-Mar-2010 | Current |
| Rishi Ganju | Director | 09-Sep-2021 | Current |
Financial Performance and Corporate Structure Insights of Atrimed Pharmaceuticals.
Atrimed Pharmaceuticals Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 44.96% increase. The company also saw a substantial improvement in profitability, with a 197.83% increase in profit. The company's net worth Soared by an impressive increase of 33.47%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Atrimed Pharmaceuticals?
In 2021, Atrimed Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Damle & Ganju Health Consultants LlpActive 4 years 11 monthsHrishikesh Damle and Ganju Krishen are mutual person
- Mahila Healthcare Private LimitedActive 4 years 10 months
Hrishikesh Damle and Ganju Krishen are mutual person
- Atrimed Plant Science Private LimitedActive 1 year 7 months
Hrishikesh Damle and Latha Damle are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 18 Oct 2024 | ₹2.00 Cr | Open |
Hdfc Bank Limited Creation Date: 31 Oct 2022 | ₹4.11 M | Open |
How Many Employees Work at Atrimed Pharmaceuticals?
Atrimed Pharmaceuticals has a workforce of 132 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Atrimed Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Atrimed Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
